SCHEMBL6607342

SCHEMBL6607342

CCc1cc(CC)n(Cc2ccc(-c3ccc(OC)cc3)cc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAPT P10636 3/20 0.43
NPBWR1 P48145 1/20 0.43
FAAH O00519 1/20 0.42
MGLL Q99685 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
IDH1 O75874 1/20 0.41
GAA P10253 1/20 0.41
GFER P55789 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CHKA P35790 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30295501 0.88 NPBWR1 (0.45) MAPTNPBWR1KDM4EALDH1A1ALOX15
SCHEMBL24828268 0.86 CYP11B1 (0.41) MAPTNPBWR1KDM4EALDH1A1ALOX15
SCHEMBL6990416 0.79 CYP1A2 (0.48) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL24828414 0.78 DCTPP1 (0.39) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL17773639 0.75 NPBWR1 (0.47) MAPTNPBWR1ALDH1A1CMA1
SCHEMBL17773619 0.75 NPBWR1 (0.47) MAPTNPBWR1CMA1
SCHEMBL3318304 0.73 NPBWR1 (0.50) MAPTNPBWR1SMN1; SMN2KDM4EALDH1A1
SCHEMBL24828267 0.72 MAPT (0.67) MAPTSMN1; SMN2GAARAB9AL3MBTL1
SCHEMBL30860079 0.72 NPBWR1 (0.48) NPBWR1CMA1
SCHEMBL13151306 0.72 TOP2A (0.47) MAPTNPBWR1L3MBTL1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465871-A1 PYRAZOLE DERIVATIVES FOR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR Bayer Corporation (US) 2004-10-13 EP disclosed
WO-2003057673-A1 1H-PYRAZOLYL DERIVATIVE COMPOUNDS, FOR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-17 WO disclosed